CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Open-market buy President and CEO bought 20,000 shares at $1.02 ($20,400)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award President and CEO acquired 136,750 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 14,589 shares (grant or award)
- 4 Open-market sale Chief Legal Officer sold 3,564 shares at $1.35 ($4,811)
- 4 Open-market sale Chief Business Officer sold 3,564 shares at $1.35 ($4,811)
- 4 Grant or award Chief Technology Officer acquired 37,500 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 3,564 shares at $1.35 ($4,811)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Financial Officer bought 17,360 shares at $1.42 ($24,651)
- 8-K Event Regulation FD disclosure
Page 4 of 17 · 326 filings